Venus Remedies gets coveted GMP certification from Libya

Our Bureau

Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in the production of injectable pharmaceuticals, including oncology, antibiotic and anticoagulant medications.

Mr. Saransh Chaudhary, CEO of Venus Medicine Research Centre, said, ” The GMP certification from Libya adds to Venus Remedies’ portfolio of international approvals from 25 regulators, complementing our existing certifications in Africa from Morocco, South Africa, Tanzania, Kenya, Uganda, Sudan and other African countries.  This GMP certification reflects our collaborative efforts in the African pharmaceutical industry, a key focus area of our global expansion strategy.”

This recognition demonstrates Venus Remedies’ persistence in adhering to stringent manufacturing standards across its global operations and is in line with the company’s commitment to enhancing healthcare solutions that benefit people the world over.

Libya’s pharmaceutical imports, valued at US $514 million in 2021, have grown at a rate of 2.81% over the previous year. Its strategic location in Africa and evolving pharmaceutical landscape provide Venus Remedies with an opportunity to contribute positively to the region’s healthcare sector.  The $46.8 billion pharmaceutical market of Africa, as in 2022, is expected to grow at a CAGR of 8.3% to reach $110.9 billion by 2023. This certification is a step towards enhancing the company’s presence in Africa, aligning with its broader vision of improving access to life-saving medicines across the continent.

Lauding the achievement, Mr. Akshansh Chaudhary, Executive Director of Venus Remedies, said, “We are thankful to our customers, partners and stakeholders for their constant support. Their trust in our company drives our pursuit of excellence.”

Venus Remedies continues to contribute to global healthcare, aiming to improve public health standards in Libya and other regions in line with its mission of advancing healthcare solutions worldwide.

Author

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Critical Path Institute Appoints Dr. Klaus Romero as CEO and Promotes Cécile Ollivier to Vice President of International Affairs

Critical Path Institute (C-Path) has appointed Klaus Romero, M.D., M.S., FCP, as its new Chief Executive Officer and has promoted Cécile Ollivier, M.S., from former Managing Director for Europe to Vice President of International Affairs. With an impressive tenure spanning more than 16 years at C-Path, Dr. Romero has held key positions […]
Dr. Klaus Romero Appointed CEO of Critical Path Institute

Subscribe Now